IQVIA Holdings Inc. (IQV) NYSE
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
IQVIA Holdings Inc.
Address
2400 Ellis Road
Durham, NC 27703
United States of America (the)
Phone
919 998 2000
Website
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Employees
89000
First IPO Date
May 09, 2013
Key Executives
| Name | Title | Pay | Year Born |
| Ari Bousbib | Chief Executive Officer & Chairman | 7.16M | 1961 |
| Eric Sherbet | Executive Vice President, General Counsel & Secretary | 1.5M | 1964 |
| Alistair Grenfell | President of Commercial Solutions | 1.7M | 1974 |
| W. Richard Staub | President of Research & Development Solutions | 1.83M | 1963 |
| Michael J. Fedock | Executive Vice President & Chief Financial Officer | 2.21M | 1976 |
| Duane Sachs | Senior Vice President of Corporate Development | 0 | N/A |
| Jeffrey A. Spaeder | Chief Medical & Scientific Officer | 0 | N/A |
| Kerri Joseph | Senior VP of Investor Relations & Treasurer | 0 | N/A |
| James G. Berkshire | Executive Vice President of Global Infrastructure & Operations | 0 | 1974 |
| Keriann Cherofsky | Senior Vice President, Corporate Controller & Chief Accounting Officer | 0 | 1985 |
Description
IQVIA Holdings Inc. is a premier global provider of sophisticated analytical insights, advanced technology solutions, and comprehensive clinical research services, catering to the life sciences industry across the Americas, Europe, Africa, and Asia-Pacific. The company's operations are structured into three key divisions: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment provides a suite of cloud-native applications, complete with implementation services, and offers real-world data solutions designed to empower life sciences and healthcare providers in generating and disseminating evidence crucial for informed decision-making and improving patient outcomes. This division also delivers strategic and operational consulting, including advanced analytics support and outsourcing of commercial processes. Furthermore, it supplies country-level performance metrics detailing pharmaceutical sales, prescribing trends, medical treatments, and promotional activities across diverse channels like retail, hospital, and mail order, with data granularity extending to regional, postal code, and individual prescriber levels. Focusing on clinical trials, the Research & Development Solutions segment offers project management, clinical monitoring, broader clinical trial support, virtual trial capabilities, and strategic planning and design services. It also manages an extensive network of laboratory services, encompassing central, genomic, bioanalytical, ADME, discovery, vaccine, and biomarker analyses. The Contract Sales & Medical Solutions segment is responsible for engaging healthcare professionals and patients, alongside providing scientific strategy and medical affairs support. IQVIA's diverse clientele includes pharmaceutical, biotechnology, medical device and diagnostic, and consumer health companies. The company maintains a strategic collaboration with HealthCore, Inc. Founded in 1982, the firm was formerly known as Quintiles IMS Holdings, Inc. before rebranding as IQVIA Holdings Inc. in November 2017. Its headquarters are located in Durham, North Carolina.
